Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Healthcare: 3 Tough Luck Tumbles – Are They Buys?

  • Broadcast in Finance
Industry Focus

Industry Focus

Featured Host
×  

Follow This Show

If you liked this show, you should follow Industry Focus.
h:899941
s:10935899
archived
Play
  • Host

Spark Therapeutics, Rite Aid, and Alnylam shares have tumbled following news, but that doesn’t necessarily make all three stocks worth buying. Stocks: ONCE, RAD, ALNY

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled